Results 1 to 10 of about 53,378 (99)

Differential effects of specific antipsychotic drugs on metabolic markers and diabetes: A register-based study on 4,909 patients with schizophrenia

European Psychiatry, 2023
Introduction Antipsychotics (AP) are used as the primary pharmaceutical treatment for schizophrenia. Randomised clinical trials (RCT) show that the initiation of AP treatment often induces side effects such as substantial weight gain and metabolic ...
M. A. Sørensen, O. Köhler-Forsberg, C. G. Rohde, A. A. Danielsen, O. Mors   +4 more
doaj   +1 more source

The Transdiagnostic Self-Injury Interview: A Feasibility Study

European Psychiatry, 2022
Introduction Non-suicidal self-injury (NSSI) is associated with emotional distress and mental disorders. In clinical samples NSSI is reported by 21% to 60% of all psychiatric patients.
J.N. Kjaer, T. Holm, V. Bliksted, T. Ellegaard, S. Dolmer, O. Mors   +5 more
doaj   +1 more source

Needs of patients with early psychosis: A comparison of patient’s and mental health care provider’s perception

Frontiers in Psychiatry, 2022
BackgroundNeeds define the capacity of a patient to benefit from health care services and a systematic assessment of needs allows planning and delivery of effective treatment to suit patients. This study aimed to understand the (a) needs felt by patients
P. V. AshaRani, Yeow Wee Brian Tan, Ellaisha Samari, Peizhi Wang, Laxman Cetty, Pratika Satghare, Jayne Ho, Shiyun Astelle Koh, Lee Zhong Yi, Charmaine Tang, Swapna Verma, Mythily Subramaniam, Mythily Subramaniam   +12 more
doaj   +1 more source

The prevalence of self-harm behavior in schizophrenia spectrum disorders: a systematic review and meta-analysis

European Psychiatry, 2022
Introduction Non-suicidal self-injury (NSSI) is intentional self-inflicted destruction of body tissue without suicidal intention, whereas deliberate self-harm (DSH) is self-inflicted destruction of body tissue regardless of intent.
E. Lorentzen, O. Mors, J.N. Kjaer
doaj   +1 more source

Alert plan-application “MySolutions” - lived experiences of users with a serious mental illness

European Psychiatry, 2022
Introduction In daily life an alert or relaps prevention plan can be a helpful tool in preventing patients with severe mental illness (SMI) from relapse. However, patients often find it hard to keep the paper version close by. A smartphone version could
J. Bom, J. Bruintjes, B. Sportel
doaj   +1 more source

Establishing a clinical service to prevent psychosis: What, how and when? Systematic review

Translational Psychiatry, 2021
The first rate-limiting step to successfully translate prevention of psychosis in to clinical practice is to establish specialised Clinical High Risk for Psychosis (CHR-P) services.
Gonzalo Salazar de Pablo, Andrés Estradé, Marcello Cutroni, Olivier Andlauer, Paolo Fusar-Poli   +4 more
doaj   +1 more source

Natural Language Processing markers in first episode psychosis and people at clinical high-risk

Translational Psychiatry, 2021
Recent work has suggested that disorganised speech might be a powerful predictor of later psychotic illness in clinical high risk subjects. To that end, several automated measures to quantify disorganisation of transcribed speech have been proposed ...
Sarah E. Morgan, Kelly Diederen, Petra E. Vértes, Samantha H. Y. Ip, Bo Wang, Bethany Thompson, Arsime Demjaha, Andrea De Micheli, Dominic Oliver, Maria Liakata, Paolo Fusar-Poli, Tom J. Spencer, Philip McGuire   +12 more
doaj   +1 more source

Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function

Translational Psychiatry, 2021
Preclinical rodent models suggest that psychosis involves alterations in the activity and glutamatergic function in the hippocampus, driving dopamine activity through projections to the striatum.
Paul Allen, Emily J. Hird, Natasza Orlov, Gemma Modinos, Matthijs Bossong, Mathilde Antoniades, Carly Sampson, Matilda Azis, Oliver Howes, James Stone, Jesus Perez, Matthew Broome, Antony A. Grace, Philip McGuire   +13 more
doaj   +1 more source

Treatment of schizophrenia evaluated via the pharmacopsychometric triangle—An integrative approach with emphasis on well-being and functioning

Schizophrenia, 2023
Quantification of treatment response is crucial to optimize outcomes for patients with schizophrenia. In this study, we evaluated the relationship between quantitative measures of clinician-rated symptom severity and self-rated side effects, well-being ...
Pernille Kølbæk, Ole Mors, Christoph U. Correll, Søren D. Østergaard   +3 more
doaj   +1 more source

Study protocol design and evaluation of a hospital-based multi-professional educational intervention: Person-Centred Psychosis Care (PCPC)

BMC Psychiatry, 2018
Background While patient involvement in mental health care is repeatedly stressed in policy documents, there are actually few studies that evaluate person-centred care interventions within psychiatric services.
Anneli Goulding, Katarina Allerby, Lilas Ali, Andreas Gremyr, Margda Waern   +4 more
doaj   +1 more source